Related Experiment Video
Updated: Jul 3, 2026

09:02
Fabricating a UV-Vis and Raman Spectroscopy Immunoassay Platform
Published on: November 10, 2016
[The fabrication of hepatitis B electrochemical immunosensor array]
1General Hospital of Guangzhou Command, Guangzhou 510010, China.
Summary
This study presents an eight-channel immunosensor array for Hepatitis B surface antigen (HBsAg) detection. The novel Hepatitis B (HB) diagnostic tool demonstrates high accuracy and reliability, aligning with ELISA results.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Analytical Chemistry
Context:
- Hepatitis B virus (HBV) infection remains a significant global health concern.
- Accurate and rapid diagnostics are crucial for effective Hepatitis B (HB) management.
- Existing diagnostic methods may have limitations in terms of speed, cost, or multiplexing capabilities.
Purpose:
- To develop a novel, integrated circuit-based immunosensor array for the detection of Hepatitis B surface antigen (HBsAg).
- To evaluate the performance, accuracy, and reliability of the developed eight-channel immunosensor for qualitative and quantitative HBsAg detection.
- To assess the clinical applicability of the immunosensor by comparing its performance with the established Enzyme-Linked Immunosorbent Assay (ELISA).
Summary:
- An eight-channel gold electrodes (GEs) array was fabricated using integrated circuit (IC) technology.
- The immunosensor was constructed by co-immobilizing thionine and Hepatitis B (HB) antibody onto gold electrodes via a cysteamine/glutaraldehyde linkage.
- Hepatitis B surface antigen (HBsAg) detection was achieved by monitoring the peak current decrease of thionine, enabling qualitative and quantitative analysis with high accuracy and reliability.
Impact:
- The developed immunosensor array offers a sensitive and reliable platform for Hepatitis B diagnostics.
- Synchronous detection of HBsAg across eight channels enhances diagnostic efficiency and throughput.
- Clinical validation demonstrated good agreement with ELISA, suggesting potential for widespread adoption in Hepatitis B (HB) screening and monitoring.

